Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Injection Site for Serratus Anterior Plane Block
NCT03183596Phase 3Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Dec 2019
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine, dexamethasone in postoperative pain, sponsored by University of Alabama at Birmingham. Planned start Dec 2019; status: withdrawn.
02
Drugs
bupivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03183596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183596.